Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer.
View Top Employees from Onconova TherapeuticsWebsite | http://www.onconova.com |
Ticker | ONTX |
Revenue | $1 million |
Funding | $77.5 million |
Employees | 33 (33 on RocketReach) |
Founded | 1998 |
Address | 12 Penns Trail, Newtown, Pennsylvania 18940, US |
Phone | (267) 759-3681 |
Technologies |
JavaScript,
HTML,
PHP
+24 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Biopharma, Oncology, Pharmaceuticals, Biotechnology, Hematology, Healthcare, Health Care, Science and Engineering |
Web Rank | 5 Million |
Keywords | Onconova, Rigosertib Fda Approval, Rigosertib, バイオ株 一覧, Onconova Therapeutics |
Competitors | Biokine Therapeutics Ltd., Calithera Biosciences, Cancer Prevention Pharmaceuticals, Inc, Concert Pharmaceuticals, Inc., VTV |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 62 Companies, NAICS Code 3254 Companies, NAICS Code 6215 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 621 Companies, NAICS Code 62151 Companies |
Looking for a particular Onconova Therapeutics employee's phone or email?
The Onconova Therapeutics annual revenue was $1 million in 2024.
Mark Guerin is the Chief Operating Officer and Chief Financial Officer of Onconova Therapeutics.
33 people are employed at Onconova Therapeutics.
Onconova Therapeutics is based in Newtown, Pennsylvania.
The NAICS codes for Onconova Therapeutics are [32, 62, 3254, 6215, 32541, 325, 621, 62151].
The SIC codes for Onconova Therapeutics are [28, 283].